Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. Its products includes: FoundationOne for solid tumors; FoundationOne Heme for blood-based cancers; FoundationACT; and FoundationFocus CDxBRCA. The company was founded by Alexis Borisy in November 2009 and is headquartered in Cambridge, MA.
